A national, multicenter, prospective, observational study to assess patient characteristics, treatment algorithms and disease management of hyperkalaemia patients with chronic kidney disease or under dialysis or with heart failure, treated with sodium zirconium cyclosilicate in Greece

Trial Identifier: D9480R00055
Sponsor: AstraZeneca
NCTID:: NCT06185660
Start Date: February 2024
Primary Completion Date: March 2025
Study Completion Date: March 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Greece Alexandroupolis, Greece, 68100
Greece Athens, Greece, 11527
Greece Athens, Greece, 12462
Greece Athens, Greece, 10676
Greece Athens, Greece, 15123
Greece Heraklion, Greece, 71500
Greece Larissa, Greece, 41110
Greece Patra, Greece, 26504
Greece Thessaloniki, Greece, 57010
Greece Thessaloniki, Greece, 54636